Company type | Corporation |
---|---|
Industry | Nanotechnology |
Headquarters | Auburn, AL , USA |
Area served | International |
Key people | CEO: Samuel M. Lawrence COO: John O. Lawrence VP, Sales & Marketing: Byron J. Cheatham Technology Development Director: James M. Beach Ph.D |
Website | www.CytoViva.com |
CytoViva, Inc. is a scientific imaging and instrumentation company that develops and markets optical microscopy and hyperspectral imaging technology for nanomaterials, pathogen and general biology applications. [1]
The company's core optical technology was invented by Vitaly Vodyanoy, [2] Physiology Professor and Director of the Biosensor Laboratory at Auburn University. CytoViva commercialized this technology in 2005 and patents for the illumination optics were issued in 2009 (US patents No. 7,542,203, [3] 7,564,623 [4]). In 2008, the company introduced hyperspectral imaging technology as an integrated solution with its patented optical microscopy capability.
The company is currently headquartered in Auburn, Alabama at the Auburn Research Park and has distribution partners worldwide. As of 2016, over 300 research laboratories worldwide utilize CytoViva technology.
CytoViva combines patented enhanced darkfield optical microscopy technology with a proprietary hyperspectral imaging capability. [5] This combination of technologies enables optical observation and spectral characterization of a wide range of nanoscale samples, including nanoparticles, pathogens and subcellular materials. [6]
Products include:
Company type | Corporation |
---|---|
Industry | Nanotechnology |
Headquarters | Auburn, AL , USA |
Area served | International |
Key people | CEO: Samuel M. Lawrence COO: John O. Lawrence VP, Sales & Marketing: Byron J. Cheatham Technology Development Director: James M. Beach Ph.D |
Website | www.CytoViva.com |
CytoViva, Inc. is a scientific imaging and instrumentation company that develops and markets optical microscopy and hyperspectral imaging technology for nanomaterials, pathogen and general biology applications. [1]
The company's core optical technology was invented by Vitaly Vodyanoy, [2] Physiology Professor and Director of the Biosensor Laboratory at Auburn University. CytoViva commercialized this technology in 2005 and patents for the illumination optics were issued in 2009 (US patents No. 7,542,203, [3] 7,564,623 [4]). In 2008, the company introduced hyperspectral imaging technology as an integrated solution with its patented optical microscopy capability.
The company is currently headquartered in Auburn, Alabama at the Auburn Research Park and has distribution partners worldwide. As of 2016, over 300 research laboratories worldwide utilize CytoViva technology.
CytoViva combines patented enhanced darkfield optical microscopy technology with a proprietary hyperspectral imaging capability. [5] This combination of technologies enables optical observation and spectral characterization of a wide range of nanoscale samples, including nanoparticles, pathogens and subcellular materials. [6]
Products include: